An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National Taskforce.

McDonagh, J; Ferguson, C; Hilmer, SN; Hubbard, RE; Lindley, RI; Driscoll, A; Maiorana, A; Wu, L; Atherton, JJ; Bajorek, BV; Carr, B; Delbaere, K; Dent, E; Duong, MH; Hickman, LD; Hopper, I; Huynh, Q; Jha, SR; Keech, A; Sim, M; Singh, GK; Villani, A; Shang, C; Hsu, M; Vandenberg, J; Davidson, PM; Macdonald, PS

An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National Taskforce.

McDonagh, J Ferguson, C

Hilmer, SN Hubbard, RE Lindley, RI Driscoll, A Maiorana, A Wu, L Atherton, JJ Bajorek, BV Carr, B Delbaere, K Dent, E Duong, MH Hickman, LD Hopper, I Huynh, Q Jha, SR Keech, A Sim, M Singh, GK Villani, A Shang, C Hsu, M Vandenberg, J Davidson, PM Macdonald, PS

Permalink

Publisher:: ELSEVIER SCIENCE INC
Publication Type:: Journal Article
Citation:: Heart Lung Circ, 2025, 34, (7), pp. 693-703
Issue Date:: 2025-07

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (656.35 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	McDonagh, J
dc.contributor.author	Ferguson, C https://orcid.org/0000-0002-2417-2216
dc.contributor.author	Hilmer, SN
dc.contributor.author	Hubbard, RE
dc.contributor.author	Lindley, RI
dc.contributor.author	Driscoll, A
dc.contributor.author	Maiorana, A
dc.contributor.author	Wu, L
dc.contributor.author	Atherton, JJ
dc.contributor.author	Bajorek, BV
dc.contributor.author	Carr, B
dc.contributor.author	Delbaere, K
dc.contributor.author	Dent, E
dc.contributor.author	Duong, MH
dc.contributor.author	Hickman, LD
dc.contributor.author	Hopper, I
dc.contributor.author	Huynh, Q
dc.contributor.author	Jha, SR
dc.contributor.author	Keech, A
dc.contributor.author	Sim, M
dc.contributor.author	Singh, GK
dc.contributor.author	Villani, A
dc.contributor.author	Shang, C
dc.contributor.author	Hsu, M
dc.contributor.author	Vandenberg, J
dc.contributor.author	Davidson, PM
dc.contributor.author	Macdonald, PS
dc.date.accessioned	2026-02-19T23:19:56Z
dc.date.available	2025-01-22
dc.date.available	2026-02-19T23:19:56Z
dc.date.issued	2025-07
dc.identifier.citation	Heart Lung Circ, 2025, 34, (7), pp. 693-703
dc.identifier.issn	1443-9506
dc.identifier.issn	1444-2892
dc.identifier.uri	http://hdl.handle.net/10453/193645
dc.description.abstract	Approximately 50% of all adults with heart failure (HF) are classified as frail. Frailty is a clinical state of 'accelerated ageing' that complicates management and results in adverse health outcomes. Despite recommendations for frailty assessment in HF guidelines, its implementation into routine clinical practice has been slow. Further, evidence to inform models of care and pharmacological treatment for individuals with HF who are classified as frail is lacking. The complexity of management underscores the importance of tailoring models of care that can improve the focus on frailty through multidisciplinary care teams. Frailty can be reduced in some cases through the comprehensive geriatric assessment model of care, integrating treatment pillars such as exercise, nutrition, social engagement and support networks, and optimised medication use. A national agenda for action on frailty in the context of HF is needed to advance policy, practice, education, and research improve health outcomes for individuals affected. In November 2023 the Australian Cardiovascular Alliance (ACvA) facilitated a national workshop on frailty and HF with key experts. This has led to the development of a frailty and HF national taskforce with the aim to address major priorities and unmet needs. This statement is first step for the taskforce in implementing a national agenda for the management of frailty in HF. Here we outline key considerations for policy, practice, education, and research in Australia.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	ELSEVIER SCIENCE INC
dc.relation.ispartof	Heart Lung Circ
dc.relation.isbasedon	10.1016/j.hlc.2025.01.012
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1102 Cardiorespiratory Medicine and Haematology, 1117 Public Health and Health Services
dc.subject.classification	Cardiovascular System & Hematology
dc.subject.classification	3201 Cardiovascular medicine and haematology
dc.subject.classification	4203 Health services and systems
dc.subject.classification	4206 Public health
dc.subject.mesh	Humans
dc.subject.mesh	Heart Failure
dc.subject.mesh	Australia
dc.subject.mesh	Frailty
dc.subject.mesh	Aged
dc.subject.mesh	Geriatric Assessment
dc.subject.mesh	Disease Management
dc.subject.mesh	Advisory Committees
dc.subject.mesh	Humans
dc.subject.mesh	Geriatric Assessment
dc.subject.mesh	Aged
dc.subject.mesh	Advisory Committees
dc.subject.mesh	Disease Management
dc.subject.mesh	Australia
dc.subject.mesh	Heart Failure
dc.subject.mesh	Frailty
dc.subject.mesh	Humans
dc.subject.mesh	Heart Failure
dc.subject.mesh	Australia
dc.subject.mesh	Frailty
dc.subject.mesh	Aged
dc.subject.mesh	Geriatric Assessment
dc.subject.mesh	Disease Management
dc.subject.mesh	Advisory Committees
dc.title	An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National Taskforce.
dc.type	Journal Article
utslib.citation.volume	34
utslib.location.activity	Australia
utslib.for	1102 Cardiorespiratory Medicine and Haematology
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)
pubs.organisational-group	University of Technology Sydney/UTS Groups/INSIGHT: Institute for Innovative Solutions for Wellbeing and Health
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
dc.date.updated	2026-02-19T23:19:54Z
pubs.issue	7
pubs.publication-status	Published
pubs.volume	34
utslib.citation.issue	7

Abstract:

Approximately 50% of all adults with heart failure (HF) are classified as frail. Frailty is a clinical state of 'accelerated ageing' that complicates management and results in adverse health outcomes. Despite recommendations for frailty assessment in HF guidelines, its implementation into routine clinical practice has been slow. Further, evidence to inform models of care and pharmacological treatment for individuals with HF who are classified as frail is lacking. The complexity of management underscores the importance of tailoring models of care that can improve the focus on frailty through multidisciplinary care teams. Frailty can be reduced in some cases through the comprehensive geriatric assessment model of care, integrating treatment pillars such as exercise, nutrition, social engagement and support networks, and optimised medication use. A national agenda for action on frailty in the context of HF is needed to advance policy, practice, education, and research improve health outcomes for individuals affected. In November 2023 the Australian Cardiovascular Alliance (ACvA) facilitated a national workshop on frailty and HF with key experts. This has led to the development of a frailty and HF national taskforce with the aim to address major priorities and unmet needs. This statement is first step for the taskforce in implementing a national agenda for the management of frailty in HF. Here we outline key considerations for policy, practice, education, and research in Australia.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/193645